These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25468095)

  • 21. [Exfoliative esophagitis while taking dabigatran].
    Scheppach W; Meesmann M
    Dtsch Med Wochenschr; 2015 Apr; 140(7):515-8. PubMed ID: 25826037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.
    Weltermann A; Brodmann M; Domanovits H; Eber B; Gottsauner-Wolf M; Halbmayer WM; Hiesmayr JM; Kyrle PA; Längle F; Roithinger FX; Watzke H; Windhager R; Wolf C; Zweiker R
    Wien Klin Wochenschr; 2012 May; 124(9-10):340-7. PubMed ID: 22576960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal association of mechanical valve thrombosis with dabigatran: a report of two cases.
    Atar S; Wishniak A; Shturman A; Shtiwi S; Brezins M
    Chest; 2013 Jul; 144(1):327-328. PubMed ID: 23880682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dabigatran and bleeding: still an emergent situation?
    Van Heukelom J; Lal Y
    Am J Med Sci; 2013 Sep; 346(3):259. PubMed ID: 23698156
    [No Abstract]   [Full Text] [Related]  

  • 25. Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
    Davis C; Robertson C; Shivakumar S; Lee M
    J Can Dent Assoc; 2013; 79():d74. PubMed ID: 23920075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.
    Alikhan R; Rayment R; Keeling D; Baglin T; Benson G; Green L; Marshall S; Patel R; Pavord S; Rose P; Tait C
    Emerg Med J; 2014 Feb; 31(2):163-8. PubMed ID: 23435652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uncontrollable haemorrhage following dabigatran prophylaxis.
    Sandhu PS; Wilson C; Dalton E; Bogdanov A
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23761516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating and assessing dabigatran drug interactions.
    Nguyen T; Wong E
    Consult Pharm; 2012 Jul; 27(7):509-12. PubMed ID: 22910132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dabigatran: will it change clinical practice?
    Wartak SA; Bartholomew JR
    Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R; Salhanick SD; Chase M; Ganetsky M
    Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dabigatran-associated subdural hemorrhage: using thromboelastography (TEG(®)) to guide decision-making.
    Neyens R; Bohm N; Cearley M; Andrews C; Chalela J
    J Thromb Thrombolysis; 2014; 37(2):80-3. PubMed ID: 23666496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
    Diogo C; Duarte J; Sobral S; Pestana P; Nzwalo H; Rita H; Sousa E Costa J
    Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of postapproval data for dabigatran.
    Redberg RF
    JAMA Intern Med; 2015 Jan; 175(1):25. PubMed ID: 25365377
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk of bleeding with dabigatran in atrial fibrillation.
    Hernandez I; Baik SH; Piñera A; Zhang Y
    JAMA Intern Med; 2015 Jan; 175(1):18-24. PubMed ID: 25365537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of a dabigatran overdose: what are possible options?
    Ratanapo S; Ungprasert P; Srivali N; Cheungpasitporn W; Bischof EF
    Am J Med Sci; 2013 Sep; 346(3):259. PubMed ID: 23974270
    [No Abstract]   [Full Text] [Related]  

  • 36. Activated prothrombin complex concentrate for the prevention of dabigatran-associated bleeding.
    Wong H; Keeling D
    Br J Haematol; 2014 Jul; 166(1):152-3. PubMed ID: 24617554
    [No Abstract]   [Full Text] [Related]  

  • 37. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L; Chen C; White J
    Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prophylaxis of stroke and embolisms in atrial fibrillation--what is new in the guidelines?].
    Lewalter T
    MMW Fortschr Med; 2012 Mar; 154(5):50-2, 54. PubMed ID: 22624265
    [No Abstract]   [Full Text] [Related]  

  • 39. Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
    Stöllberger C; Rakusan S; Wimpissinger FT; Finsterer J
    Thromb Haemost; 2012 Sep; 108(3):579-81. PubMed ID: 22739630
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuation of dabigatran therapy in "real-world" practice in Hong Kong.
    Ho MH; Ho CW; Cheung E; Chan PH; Hai JJ; Chan KH; Chan EW; Leung GK; Tse HF; Siu CW
    PLoS One; 2014; 9(8):e101245. PubMed ID: 25084117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.